Crossmark

CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated

Crossref DOI link: https://doi.org/10.1007/s13277-016-5157-0

Published Online: 2016-07-22

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yin, Lei

Liu, Shuai

Li, Chensheng

Ding, Sentai

Bi, Dongbin

Niu, Zhihong

Han, Liping

Li, Wenjia

Gao, Dexuan

Liu, Zheng

Lu, Jiaju
Funding

Funding for this research was provided by:

Natural Science Foundation of Shandong Province (CN) (2014ZRB14081)

Shandong Key Research and Development Project (2015GSF118055)

Medicine and Healthcare Technology Development Project of Shandong Province (2014WS0341))

Natural Science Foundation of Shandong Province (CN) (2014ZRB14513))
License Information

License valid from 2016-07-22

Document is current

Any future updates will be listed below